| Product Code: ETC7558398 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Antimicrobial Resistance Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 Indonesia Antimicrobial Resistance Market - Industry Life Cycle |
3.4 Indonesia Antimicrobial Resistance Market - Porter's Five Forces |
3.5 Indonesia Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Indonesia Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Indonesia Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 Indonesia Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 Indonesia Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Indonesia |
4.2.2 Growing awareness about the importance of antimicrobial resistance |
4.2.3 Government initiatives to tackle antimicrobial resistance |
4.3 Market Restraints |
4.3.1 Lack of effective regulations and policies for antimicrobial use |
4.3.2 Limited access to quality healthcare services in rural areas |
5 Indonesia Antimicrobial Resistance Market Trends |
6 Indonesia Antimicrobial Resistance Market, By Types |
6.1 Indonesia Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Indonesia Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 Indonesia Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 Indonesia Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 Indonesia Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 Indonesia Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 Indonesia Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Indonesia Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 Indonesia Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 Indonesia Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 Indonesia Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 Indonesia Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 Indonesia Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Indonesia Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 Indonesia Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 Indonesia Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 Indonesia Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Indonesia Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 Indonesia Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 Indonesia Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 Indonesia Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 Indonesia Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 Indonesia Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 Indonesia Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 Indonesia Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 Indonesia Antimicrobial Resistance Market Export to Major Countries |
7.2 Indonesia Antimicrobial Resistance Market Imports from Major Countries |
8 Indonesia Antimicrobial Resistance Market Key Performance Indicators |
8.1 Percentage of healthcare professionals trained on antimicrobial resistance |
8.2 Number of reported cases of antimicrobial-resistant infections |
8.3 Level of investment in research and development for new antimicrobial drugs |
9 Indonesia Antimicrobial Resistance Market - Opportunity Assessment |
9.1 Indonesia Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Indonesia Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Indonesia Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 Indonesia Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 Indonesia Antimicrobial Resistance Market - Competitive Landscape |
10.1 Indonesia Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 Indonesia Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here